Prior dengue infection reshapes innate immunity, boosting vaccine efficacy. Vaccination alone fails to replicate these immune ...
The acute SBI rate was 0.07 during the 12-month study period, which met the predefined success rate of less than 1 acute SBI per patient per year. The Food and Drug Administration (FDA) has approved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback